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Low uptake of postpartum screening for Type 2 diabetes in women after a 
diagnosis of gestational diabetes 
 
Postpartum screening rates for Type 2 diabetes after a diagnosis of gestational diabetes are low across 
many high-income countries, ranging from 20 to 58% up to 1 year after delivery [1,2]. Subsequent 
annual follow-up rates plateau at 20% [1].   
 
We conducted an audit to assess postnatal diabetes screening rates in 233 women living in the city of 
Southampton with a history of gestational diabetes, diagnosed using WHO criteria. Current local 
practice involves giving verbal and written information regarding the risks of Type 2 diabetes after 
pregnancy at the initial consultation. After delivery and before discharge, all women are 
recommended to undergo postnatal glucose testing and are informed verbally and in writing to contact 
their general practitioner for annual ongoing screening. A copy of this letter is sent to the woman’s 
general practitioner.  
 
The women included in our audit were aged 30.6 ± 5.2 years, 42.9% were from an Asian ethnic 
background and 39.9% were white. The mean BMI was 29.6 ± 7.2 kg/m2, with 28.6% of the women 
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In all, 229 women (98.3%) had a fasting plasma glucose test before discharge to the community. 
Three had impaired fasting glycaemia but normal results on re-testing.  A total of 80 women (34.3%) 
had glucose testing in the first year postpartum. The results for three women were consistent with a 
diagnosis of diabetes and another three women had impaired fasting glycaemia. Subsequently, 12.2% 
(16 of the 131 who were ≥2 years postpartum) and 17.8% (eight of the 45 who were ≥3 years 
postpartum) were screened 2 and 3 years after delivery, respectively. Two years after delivery, two 
women had elevated fasting plasma glucose levels and a further woman was diagnosed with Type 2 
diabetes. Three years postpartum, one woman had impaired fasting glycaemia and another was 
diagnosed with Type 2 diabetes. Obese women were less likely to attend screening than women with a 
normal BMI (P=0.011). Screening rates varied by postcode district from 22.5 to 50.0%. There was no 
association between age, ethnicity, diabetes treatment during pregnancy or parity and the likelihood of 
glucose testing 1 year postpartum. 
 
In contrast to the high immediate postnatal diabetes screening rates in hospital, the low long-term 
rates of postpartum screening in women with a history of gestational diabetes represents a missed 
opportunity to prevent diabetes and its complications.  
 
The follow-up of gestational diabetes crosses the divide between primary and secondary care and 
involves two secondary care specialities, diabetes and obstetrics. A proportion of women may 
therefore be lost because of ambiguity between primary and secondary care responsibilities for 
postnatal screening [1]. Poor communication and a lack of agreed universal protocols across primary 
and secondary care have previously accounted for poor interdisciplinary co-ordination of care. 
Despite the discharge letters, the importance of screening within primary care may not be fully 
appreciated [3]. Local general practitioners have highlighted the large volume of correspondence from 
secondary care, which makes it easy to miss information. Providing an action request as a bullet point 
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prompt the practice to add the woman to a practice-based gestational diabetes register and promote 
annual recall and review according to the National Institute for Health and Care Excellence guideline 
standards.  
 
In South Australia, a Gestational Diabetes Mellitus Recall Register was set up that sends a reminder 
letter ~15 months after a women’s expected delivery date that they should be screened for diabetes 
[4]. In 2009, the scheme resulted in 56.3% of women on the register who returned the update form 
returning for postpartum screening [5]. A similar scheme in Ontario, Canada sends postal reminders 
to women and their doctors. This led to a screening increase to 60.5% (49/81 women), compared with 
14.3% (5/35 women) where no reminder was sent [6].  Financial rewards through the Quality and 
Outcomes Framework may be needed to create a register and incentivize primary care to screen for 
diabetes.  
 
Although we cannot ascertain the reasons for postcode differences in screening, this may reflect 
differences in deprivation or individual general practice policies. We do not know if women were 
invited and did not attend or whether there was no recall. High BMI was the only demographic factor 
associated with the uptake of screening. This may relate to hesitancy in this population to make 
lifestyle changes to manage their diabetes risk, or obesity may be a proxy marker for deprivation.  
 
More than 40% of our cohort were from an Asian background, in whom language and communication 
may be a barrier to understanding information given by healthcare professionals [7]. Postnatal 
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It is possible that our estimates of screening are low because some women may have moved out of the 
city of Southampton and received screening elsewhere.  
 
Our audit found low rates of annual postpartum screening and calls for improved communication 
between professionals and women from all backgrounds to raise awareness of the opportunity to 
prevent diabetes and its complications. 
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